de Haas ERM - Search Results

1

Vismodegib for giant, locally advanced, basal cell carcinoma and its complex position in clinical practice.

Koekelkoren FHJ, Roodbergen SL, Baerveldt EM, Maat APWM, Monserez DA, Grünhagen DJ, Mureau MAM, de Haas ERM, Nijsten TEC, Wakkee M. Koekelkoren FHJ, et al. Among authors: de haas erm. JAAD Case Rep. 2019 Mar 1;5(3):267-270. doi: 10.1016/j.jdcr.2018.11.002. eCollection 2019 Mar. JAAD Case Rep. 2019. PMID: 30891477 Free PMC article. No abstract available.

2

[Basal cell carcinoma: often more than one].

Flohil SC, Koljenović S, de Haas ER, Overbeek LI, de Vries E, Nijsten T. Flohil SC, et al. Ned Tijdschr Geneeskd. 2011;155(47):A4110. Ned Tijdschr Geneeskd. 2011. PMID: 22129810 Dutch.

3

Population education in preventing skin cancer: from childhood to adulthood.

de Haas ER, Nijsten T, de Vries E. de Haas ER, et al. J Drugs Dermatol. 2010 Feb;9(2):112-6. J Drugs Dermatol. 2010. PMID: 20214171 Review.

4

A Retrospective Review of Reconstructive Options and Outcomes of 202 Cases Large Facial Mohs Micrographic Surgical Defects, Based on the Aesthetic Unit Involved.

van Leeuwen AC, The A, Moolenburgh SE, de Haas ER, Mureau MA. van Leeuwen AC, et al. J Cutan Med Surg. 2015 Nov-Dec;19(6):580-7. doi: 10.1177/1203475415586665. Epub 2015 May 18. J Cutan Med Surg. 2015. PMID: 25986315

5

Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands.

Flohil SC, Koljenović S, de Haas ER, Overbeek LI, de Vries E, Nijsten T. Flohil SC, et al. Br J Dermatol. 2011 Oct;165(4):874-81. doi: 10.1111/j.1365-2133.2011.10488.x. Br J Dermatol. 2011. PMID: 21711333

6

Question the obvious.

Nijsten T, de Haas ER, Neumann MH. Nijsten T, et al. Arch Dermatol. 2007 Nov;143(11):1429-32. doi: 10.1001/archderm.143.11.1429. Arch Dermatol. 2007. PMID: 18025368 Review. No abstract available.

7

Red light ALA-PDT for large areas of actinic keratosis is limited by severe pain and patient dissatisfaction.

Middelburg TA, Nijsten T, Neumann MH, de Haas ER, Robinson DJ. Middelburg TA, et al. Photodermatol Photoimmunol Photomed. 2013 Oct;29(5):276-8. doi: 10.1111/phpp.12055. Photodermatol Photoimmunol Photomed. 2013. PMID: 24001386 Clinical Trial. No abstract available.

8

Treatment of choice in superficial basal cell carcinoma.

de Haas ER. de Haas ER. Br J Dermatol. 2015 Mar;172(3):563. doi: 10.1111/bjd.13653. Br J Dermatol. 2015. PMID: 25776243 No abstract available.

9

Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial.

de Vijlder HC, Sterenborg HJ, Neumann HA, Robinson DJ, de Haas ER. de Vijlder HC, et al. Acta Derm Venereol. 2012 Nov;92(6):641-7. doi: 10.2340/00015555-1448. Acta Derm Venereol. 2012. PMID: 22964973 Free article. Clinical Trial.

10

Microscopic distribution of protoporphyrin (PpIX) fluorescence in superficial basal cell carcinoma during light-fractionated aminolaevulinic acid photodynamic therapy.

de Haas ER, de Bruijn HS, Sterenborg HJ, Neumann HA, Robinson DJ. de Haas ER, et al. Acta Derm Venereol. 2008;88(6):547-54. doi: 10.2340/00015555-0508. Acta Derm Venereol. 2008. PMID: 19002337 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters